A PHP Error was encountered

Severity: Notice

Message: Undefined index: HTTP_ACCEPT_LANGUAGE

Filename: controllers/welcome.php

Line Number: 7

Densmore Laboratoire Pharmaceutique

Research & Development

DENSMORE has it own research & development laboratory in Monaco who works with an international scientific committee and has partnerships with universities hospitals.

Densmore laboratory has a strong partnerships with a network of 8 universities, 4 University Hospitals, and more than 400 research laboratories.

Our products are the result of more than 70 years of expertise in plants extracts, vitamins and minerals.

Our formulas are developed on 4 criteria, pharmaceutical quality, components synergy, best bioavailability and adapted dosage.

Densmore is involved in research in several domains:

- Ophthalmology

for the protection of the macula, the treatment of the cornea and the neuroprotection. For this activity, Densmore is part of the OPHTA BIOTECH association

- Gynecology

for the wellbeing of women

Other products are currently under development and undergoing phase III clinical trials.

  • Award of innovation and research

Densmore has recently received two awards of innovation and research that reward both research unit and all of its range. We are proud to have been rewarded, once again, with the GOLD prize « Century International Quality ERA Award » Biotechnology category for our quality program and more specifically for our label Iprotect® (award ceremony was the 9 mars 2014 in Geneva)

  • Our conviction

The overall care of pathologies associated drug treatment and diet and lifestyle rules up to the prescription of nutritional supplements. The correlation between eating behavior and the appearance of certain diseases is widely demonstrated.

Our belief is that the intake of specific food supplements in XXI century will become an essential approach in the prevention or correction and the management of many chronic diseases. We believe this will also be part of the new Public health strategy in developed countries.